AITHYRA is a research institute founded in September 2024, hosted by the Austrian Academy of Sciences (OeAW) with significant funding from the Boehringer Ingelheim Foundation. Its mission is to fundamentally transform biomedical science by embedding artificial intelligence as a co-pilot throughout the entire scientific process, from hypothesis generation and experimental design to biological interpretation and therapeutic innovation. The institute aims to combine academic, corporate, and startup approaches, focusing on areas like cancer, immunology, infectious diseases, and neurodegenerative disorders.